Christine Will
AbbVie (United States)(US)
Publications by Year
Research Areas
Epigenetics and DNA Methylation, Acute Lymphoblastic Leukemia research, Acute Myeloid Leukemia Research, Lymphoma Diagnosis and Treatment, NF-κB Signaling Pathways
Most-Cited Works
- → H2S and NO cooperatively regulate vascular tone by activating a neuroendocrine HNO–TRPA1–CGRP signalling pathway(2014)369 cited
- → The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells(2010)355 cited
- → Histone Methyltransferase MMSET/NSD2 Alters EZH2 Binding and Reprograms the Myeloma Epigenome through Global and Focal Changes in H3K36 and H3K27 Methylation(2014)236 cited
- → A physical sciences network characterization of non-tumorigenic and metastatic cells(2013)178 cited
- → The histone methyltransferase MMSET/WHSC1 activates TWIST1 to promote an epithelial–mesenchymal transition and invasive properties of prostate cancer(2012)159 cited
- → UTX/KDM6A Loss Enhances the Malignant Phenotype of Multiple Myeloma and Sensitizes Cells to EZH2 inhibition(2017)135 cited
- → A Mutation in Histone H2B Represents a New Class of Oncogenic Driver(2019)101 cited
- → MMSET/WHSC1 enhances DNA damage repair leading to an increase in resistance to chemotherapeutic agents(2016)91 cited
- → MMSET stimulates myeloma cell growth through microRNA-mediated modulation of c-MYC(2012)86 cited
- → An activating mutation of the NSD2 histone methyltransferase drives oncogenic reprogramming in acute lymphocytic leukemia(2018)59 cited